Short answer: Jornay PM and Vyvanse are both ADHD stimulants, but they are different drugs with different release mechanisms, dosing, and typical use cases.
Key differences
- Active ingredients
- Jornay PM: methylphenidate (an MPH stimulant)
- Vyvanse: lisdexamfetamine (a prodrug of dextroamphetamine)
- How and when you take them
- Jornay PM: taken once daily in the evening (PM). It’s designed to start releasing methylphenidate in the morning after you wake up, to help with early-morning ADHD symptoms.
- Vyvanse: taken once daily in the morning. It’s a prodrug that is converted to active dextroamphetamine in the body.
- Onset and duration
- Vyvanse: usually starts within about 1 hour, with effects lasting roughly 10–12 hours (varies by person).
- Jornay PM: intended to provide coverage in the morning after an evening dose, with a similar overall daily duration (roughly 8–12 hours, depending on individual factors).
- Dosing patterns
- Vyvanse: typically started at around 30 mg daily and titrated up; common daily doses range broadly, with a max around 70 mg daily (per label and doctor guidance).
- Jornay PM: dosing is individualized, starting at a low nightly dose (often 20 mg) and may be increased in small steps; maximum daily dose is determined by the prescribing information.
- Why someone might choose one over the other
- Jornay PM can be helpful if you have trouble with morning symptoms and prefer not to take medication right when you wake up, or you want a single evening dose.
- Vyvanse is a straightforward morning dose and is often chosen for its prodrug profile, which can lower some misuse concerns and provides a steady release.
- Side effects and safety (both are stimulants)
- Common: decreased appetite, weight loss, trouble sleeping, stomach upset, increased heart rate or blood pressure, irritability or anxiety.
- Other considerations: may affect growth in children with long-term use; can trigger or worsen anxiety, tics, or mood symptoms in some people; risk of cardiovascular events in those with certain heart conditions.
- Abuse potential: Vyvanse’s prodrug design can reduce the potential for misuse compared with some non-prodrug stimulants, but both carry abuse risk and should be used exactly as prescribed.
- Practical considerations
- Insurance/cost: Vyvanse has generic versions in many places; Jornay PM is often brand-only (which can affect cost/coverage).
- Interactions: both interact with other stimulants and MAO inhibitors; talk to your clinician about other medications, caffeine, or supplements.
Which one might be right for you?
- If you’re looking to cover morning ADHD symptoms and prefer a single evening dose, Jornay PM could be appealing.
- If you want a straightforward morning dose with a well-established, widely used option, Vyvanse is a strong choice.
- Your past response to stimulants (whether you’ve used methylphenidate or amphetamine-type meds), any heart or psychiatric history, and cost/insurance will influence the best pick.
If you’d like, tell me:
- Your age (or age of the person)
- Any previous stimulant use and response
- Whether you need morning-only coverage or are okay with an evening dose
- Any medical conditions or meds you’re taking
I can tailor a more specific comparison and help you think through what to discuss with your clinician. This is not medical advice—please consult a prescriber for dosing and safety.